Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin-Reference-Cited by-同舟云学术

Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin

Published:2003-10 Issue:2 Volume:20 Page:181-195
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Müller Beat,Kasper Marlis,Surber Christian,Imanidis Georgios

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. Percutaneous absorption: theoretical description;Albery;J. Pharm. Pharmacol.,1979

2. Percutaneous penetration enhancement and its quantification;Bach;Eur. J. Pharm. Biopharm.,1998

3. Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro;Betz;Int. J. Pharm.,2001

4. Quantitative evaluation of drug-induced erythema by using a tristimulus colour analyzer: experimental design and data analysis;Chan;Skin Pharmacol.,1993

5. Bioequivalence and Bioavailability Requirements. Title 21. Code of Federal Regulations, Vol. 5. US Government Printing Office, Washington, DC, pp. 190–191.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the ¹H‐NMR Profiling of Six Edible Mushrooms Consumed in the Northeastern Highlands of Puebla, Mexico;Chemistry & Biodiversity;2024-05-06

2. Human Skin Drug Metabolism: Relationships between Methyl Salicylate Metabolism and Esterase Activities in IVPT Skin Membranes;Metabolites;2023-08-09

3. Vibrational spectra and quantum chemical investigations on nicotinium nitrate monohydrate single crystal for anti bacterial studies;Chemical Physics Impact;2023-06

4. Theoretical structural analysis (FT-IR, FT-R), solvent effect on electronic parameters NLO, FMO, NBO, MEP, UV (IEFPCM model), Fukui function evaluation with pharmacological analysis on methyl nicotinate;Computational and Theoretical Chemistry;2022-11

5. Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas;Pharmaceutics;2022-08-01